Cheng Leng Chan
- Co-authors
- Zhaojin ChenBee Choo TaiGilbert LauCynthia SungShu Chuen LiHio Teng LeongYih Yian SitohJohn Abisheganaden
- Topics
- Pharmacovigilance and Adverse Drug Reactions (6 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Viral Infections and Immunology Research (3 papers)
- Cited by
- ToxicologyPharmacology
- Partner nations
- SingaporeAustraliaUnited Kingdom
In The Last Decade
Cheng Leng Chan
15 papers receiving 248 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 80
- Toxicology 68
- Infectious Diseases 38
- Oncology 35
- Pharmacology 33
Countries citing papers authored by Cheng Leng Chan
This map shows the geographic impact of Cheng Leng Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Leng Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Leng Chan more than expected).
Fields of papers citing papers by Cheng Leng Chan
This network shows the impact of papers produced by Cheng Leng Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Leng Chan. The network helps show where Cheng Leng Chan may publish in the future.
Co-authorship network of co-authors of Cheng Leng Chan
This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Leng Chan. A scholar is included among the top collaborators of Cheng Leng Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Leng Chan. Cheng Leng Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 21 | |
| 6 | 18 | |
| 7 | 2 | |
| 8 | 10 | |
| 9 | 5 | |
| 10 | 82 | |
| 11 | 29 | |
| 12 | 4 | |
| 13 | 26 | |
| 14 | 29 | |
| 15 | 17 |
About Cheng Leng Chan
Cheng Leng Chan is a scholar working on Toxicology, Medical Laboratory Technology and Animal Science and Zoology, having authored 15 papers that have together received 254 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Toxicology (68 citations), Pharmacology (80 citations) and Pharmacology (33 citations). Cheng Leng Chan has collaborated with scholars based in Singapore, Australia and United Kingdom. Frequent co-authors include Zhaojin Chen, Bee Choo Tai, Gilbert Lau, Cynthia Sung, Shu Chuen Li, Hio Teng Leong, Yih Yian Sitoh, John Abisheganaden, Ganga Ganesan and C. C. Tchoyoson Lim. Their work appears in journals such as Radiology, Frontiers in Pharmacology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.